Crossmark

Fetal behavior and gestational serotonin reuptake inhibitor exposure: relationships between behavior, drug dosage, plasma drug level, and a measure of drug bioeffect

Crossref DOI link: https://doi.org/10.1038/s41386-024-01923-1

Published Online: 2024-08-10

Published Print: 2024-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Salisbury, Amy L.

Anderson, George M. https://orcid.org/0000-0002-9483-9151
Yang, Amy

Stika, Catherine S. https://orcid.org/0000-0001-7186-1877
Rasmussen-Torvik, Laura J.

Gollan, Jacqueline K.

Wisner, Katherine L.
Funding

Funding for this research was provided by:

U.S. Department of Health & Human Services | NIH | National Institute of Mental Health (R01-MH78033, R01-MH78033, R01-MH78033)

U.S. Department of Health & Human Services | NIH | National Institute of Mental Health

U.S. Department of Health & Human Services | NIH | National Institute of Mental Health

U.S. Department of Health & Human Services | NIH | Eunice Kennedy Shriver National Institute of Child Health and Human Development (U54HD085601)

Asher Center for the Study and Treatment of Depressive Disorders, Chicago, IL
License Information

Text and Data Mining valid from 2024-08-10

Version of Record valid from 2024-08-10
More Information

Article History

Received: 8 January 2024

Revised: 3 July 2024

Accepted: 8 July 2024

First Online: 10 August 2024

Competing interests

: The authors declare no competing interests.

Document is current

Any future updates will be listed below